Clinical Trial: Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy.

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842302) titled 'Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy.' on July 20.

Brief Summary: Multiple Sclerosis (MS) is a chronic neurological disease impacting 2.8 million individuals globally, with fatigue being its most debilitating symptom, reported by 75% of patients. Despite its prevalence, the pathophysiology of MS-related fatigue remains poorly understood, and current pharmacological treatments have limited effectiveness. This research addresses this critical gap by investigating two non-invasive brain stimulation (NIBS) techniquestranscranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)as inn...